Upside, Downside Movers in the Morning
Upside:
-ATAI +34% (confirms to be acquired by Lilly for $6.75/shr plus CVR worth up to $2.50/shr to advance treatment-resistant depression therapies)
-DSGR +25% (agrees to be acquired by LKCM Headwater for $35.00/shr in cash)
-GHRS +15% (higher in sympathy with ATAI)
-MAN +14% (earnings, guidance)
-CMPS +8.5% (reports Phase 2 COMP360 support analysis in PTSD; higher in sympathy with ATAI)
-ABUS +7.8% (files three international lawsuits against Pfizer/BioNTech over COVID-19 vaccine LNP patents; receives $178M from Moderna, plans up to $230M share repurchases)
-UNH +6.8% (earnings, guidance)
-ARTL +6.4% (reports nonclinical ART26.12 data in osteoarthritis pain)
-JBHT +6.1% (earnings, color)
-HUM +5.4% (higher in sympathy with UNH)
-ABT +3.8% (earnings, guidance; investigating cyber incident in Cancer Diagnostics business)
-BIDU +2.4% (seeking dual-primary listing in Hong Kong)
Downside:
-ASTS -13% (prices $1B 1.625% convertible senior unsecured notes due 2034 at $79.57/shr conversion price)
-FEIM -11% (earnings, color)
-TSM -4.3% (earnings, guidance)
-UAL -3.6% (earnings, guidance)
-ETSY -2.7% (BTIG Cuts ETSY to Neutral from Buy)
-GE -2.6% (earnings, guidance)
-LULU -2.0% (Truist Cuts LULU to Sell from Hold, price target: $94 from $115)
Positions: None.